Mode
Text Size
Log in / Sign up

Octenidine gel plus hydrogel dressing improved healing progress versus silver-containing calcium alginate dressing in patients with chronic venous leg ulcers over 4 weeksNew gel therapy helps heal stubborn leg wounds faster than old silver dressings

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider octenidine gel plus hydrogel dressing for chronic venous leg ulcers, though safety data were not reported.

This randomized controlled trial evaluated wound healing in 60 patients with chronic venous leg ulcers. Participants were assigned to receive either octenidine gel plus hydrogel dressing or a silver-containing calcium alginate dressing. The study followed patients for 4 weeks to assess outcomes.

The primary outcome measured wound healing progress using the RESVECH 2.0 Scoring Scale. Secondary outcomes included wound size, wound edges, tissue in the wound bed, exudate, and signs of infection or inflammation. The experimental group demonstrated statistically significant improvements in the RESVECH 2.0 total score and parameters. In contrast, the control group experienced no significant changes in these metrics.

Safety and tolerability data were not reported. Adverse events, serious adverse events, discontinuations, and overall tolerability were not reported. The study did not specify p-values or confidence intervals for the reported statistical significance.

The authors suggest that incorporating hydrogel-based antiseptic dressings into standard treatment protocols may improve patient outcomes and reduce healing time. However, the absence of reported safety data and specific statistical values limits the precision of the clinical interpretation.

Imagine waking up to find a sore on your leg that has been there for months. It does not go away with standard creams or bandages. This is the reality for many people with venous leg ulcers. These open sores are painful and can lead to serious infections if they do not heal.

Venous leg ulcers are a major problem for healthcare systems. They happen when blood flows poorly back up from the legs. This poor circulation causes skin damage and slow healing. Many patients suffer from these wounds for years. The current treatments often fail to close the wound quickly enough.

But here is the twist. A new study suggests a different approach might work better. Doctors tested a combination of an antiseptic gel and a special dressing. This new method outperformed the traditional silver-based dressings used for decades.

The science behind this works like a smart factory. Think of a wound as a busy construction site. The old silver dressings act like a barrier that keeps dirt out. However, they do not actively clean the site or keep it moist. The new hydrogel dressing acts like a sponge that holds water. This moisture keeps new skin cells moving fast. The octenidine gel acts like a security guard that kills bacteria without hurting the healing tissue.

The researchers ran a strict test to see if this worked in real people. They enrolled sixty patients who had chronic wounds that had not healed. Half of the patients got the new gel and hydrogel dressing. The other half received the standard silver-containing calcium alginate dressing. Everyone was treated for four weeks.

After four weeks, the results were clear. The group using the new gel and hydrogel saw big improvements. Their wounds got smaller and the edges started to pull together. The tissue inside the wound looked healthier and pinker. Signs of infection and inflammation disappeared quickly. The group using the silver dressing showed no significant changes during the same time.

This doesn't mean this treatment is available yet.

The study found that the new combination therapy was superior in every way measured. The overall score for wound health was much higher in the experimental group. This means the new method addresses more problems at once. It cleans the wound while keeping it moist for healing.

Experts say this fits well into the bigger picture of wound care. Chronic wounds need more than just a bandage. They need an environment that supports cell growth. The new therapy creates that perfect environment. It may become a standard option for doctors in the future.

Patients might soon have more choices for treating stubborn wounds. If this therapy works well in larger groups, it could reduce healing time significantly. People could return to normal activities sooner. The pain and discomfort of open sores would end faster.

However, there are limits to what this study can prove. The trial only included sixty patients. This is a small number for such a serious condition. The study was also conducted in a controlled hospital setting. Real homes and bathrooms are different from hospital rooms. More research is needed to see if the results hold up everywhere.

The road ahead involves larger trials and safety checks. Doctors will need to test this on more diverse groups of people. They must also check for long-term side effects. Once approved, insurance companies will decide if they will cover the cost. Until then, patients should talk to their doctor about current options.

The future of wound care looks promising. New materials and smarter therapies are changing how we treat chronic sores. This new gel and hydrogel combination is a strong step forward. It offers hope for millions of people suffering from non-healing wounds.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
IntroductionVenous leg ulcers (VLUs) represent a major chronic wound condition associated with high recurrence rates, prolonged healing, and substantial socioeconomic burden. Hydrogels have recently gained attention as effective wound dressings due to their moisture-retentive and biocompatible properties. This study aimed to evaluate the clinical effectiveness of a combined therapy using octenidine gel and a hydrogel dressing compared to a silver-containing calcium alginate dressing in patients with VLUs.MethodsA randomized controlled trial was conducted, enrolling 60 patients with chronic VLUs. Participants were randomly assigned to either an experimental group (octenidine gel + hydrogel dressing) or a control group (silver-containing calcium alginate dressing). Wound healing progress was assessed using the RESVECH 2.0 Scoring Scale, which evaluates six wound parameters of effective wound healing. Measurements were taken at baseline and after 4 weeks of treatment.ResultsAfter 4 weeks, the experimental group showed statistically significant improvements in wound size, wound edges, tissue in the wound bed, exudate, infection/inflammation signs, and overall RESVECH 2.0 total score. No significant changes were observed in the control group. Between-group comparisons confirmed superior healing outcomes in the experimental group.DiscussionThe combination of octenidine gel and a hydrogel dressing significantly enhanced healing outcomes in patients with VLUs compared to conventional silver-containing dressings, suggesting that hydrogel-based antiseptic therapy is an effective alternative for VLU management. Given the chronic nature and high recurrence rates of VLUs, incorporating hydrogel-based antiseptic dressings into standard treatment protocols may improve patient outcomes and reduce healing time.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.